tert-Butyl 3-bromo-5-formylbenzoate

Catalog No.: 
ACGAXT067
CAS No.: 
1018948-99-6
Molecular Formula: 
C12H13BrO3
Molecular Weight: 
285.14
tert-Butyl 3-bromo-5-formylbenzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$99.00In stockInquiry
5g95%$350.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-bromo-5-formylbenzoate
IUPAC Nametert-butyl 3-bromo-5-formylbenzoate
MDL No.MFCD22543863
Molecular FormulaC12H13BrO3
Molecular Weight285.14
SMILESO=C(OC(C)(C)C)C1=CC(C=O)=CC(Br)=C1
InChI KeyWJYXOHSLYSXYCL-UHFFFAOYSA-N
Synonymtert-butyl 3-bromo-5-formylbenzoate;T-BUTYL-3-BROMO-5-FORMYLBENZOATE;Benzoic acid, 3-bromo-5-formyl-, 1,1-dimethylethyl ester;1,1-Dimethylethyl 3-bromo-5-formylbenzoate
CAS No.1018948-99-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACGAXT067 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYVDT351 route compound structure diagram
    ACYVDT3511149752-66-8In Stock
  2. Then
  3. ACGAXT067 route product structure diagram
    ACGAXT0671018948-99-6In Stock
Inquiry

2. ACGAXT067 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOAXM756 route compound structure diagram
    ACOAXM75669038-74-0In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGAXT067 route product structure diagram
    ACGAXT0671018948-99-6In Stock
Inquiry

3. ACGAXT067 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDTAI056 route compound structure diagram
    ACDTAI056398119-27-2In Stock
  4. Then
  5. ACGAXT067 route product structure diagram
    ACGAXT0671018948-99-6In Stock
Inquiry

Comments (0)